medigraphic.com
ISSN 0210-5187 (Digital)

2007, Número 5

<< Anterior Siguiente >>

Med Cutan Iber Lat Am 2007; 35 (5)


Productos de relleno inyectables en dermocosmética. Tipos y efectos secundarios

Serrano-Grau P, Mascaró-Galy JM, Iranzo P, Navarra E, Ferrando J

Idioma: Español
Referencias bibliográficas: 54
Paginas: 209-218
Archivo PDF: 340.21 Kb.


RESUMEN

En este artículo revisamos los diferentes productos de relleno y los posibles efectos adversos que pueden causar. Los productos de relleno se clasifican en permanentes y no permanentes. A su vez los permanentesse dividen en: gel de polímero homogéneo, suspensión de microesferas o fragmentos de polímeros insolubles y líquido reabsorbible y suspensión de microesferas de polímero lentamente degradable y líquido reabsorbible. Entre los no permanentesencontramos los geles de colágeno, los de ácido hialurónico, los formados por microesferas dehidroxiapatita cálcica en un gel de carboximetilcelulosa y los formados por una combinación de ácido hialurónico y dextranómeros.La mayoría de los efectos adversosproducidos por estas sustancias son leves y transitorios pero también se han descrito efectos graves como reacciones de hipersensibilidad y presencia de siliconomas en el lugar de inyección y a distancia incluso al cabo de muchos años. Aunque es frecuente encontrar una reacción a cuerpo extraño a nivel histológico no es tan frecuente que se manifieste clínicamente.Para reducir las reacciones adversas es importante realizar estudios a largo plazo de estos productos y que estos procedimientos se realicen en centrosmédicos por especialistas debidamente formados.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Christensen L, Breiting V, Janseen M, Vuust J, Hodgall E. Adverse reactions to injectable soft tissue permanent fillers. Aesth PlastSurg 2005;29:34-48.

  2. Hexsel DM, Hexsel CL, Iyengar V. Liquid injectable silicone. History, mechanism of action, indications, technique, and complications. Semin Cutan Med Surg 2003;22:107-14.

  3. Bakker-Woudenberg IA, Lokerse AF, TenKate MT, Melissen PM, Van Vianen W. Eur J Clin Microbiol Infect Dis 1993;12 (Suppl.10):61-67.

  4. Barlow R, Torres W, Sones P, Someren A.Sonographic demonstration of migrating silicone. AJR Am J Roentgenol 1980;35: 170-71.

  5. Gregoriadis G. Liposomes as immunological adjuvants. Approaches immunopotentiation including ligand-mediated targeting to macrophages. Res Immunol1992;43:178-85.

  6. Thomsen JL, Christensen L, Nielsen M,Brandt B, Breiting VB, Felby S, Nielsen E.Histologic changes and silicone concentra-tions in human breast tissue surroundingsilicone breast prostheses. Plast ReconstrSurg1990;85:38-41.

  7. Wickham MG, Rudolph R, Abraham JL. Silicon identification in prosthesis-associated fibrous capsules. Science1978;199:437-39.

  8. Winding O, Christensen L, Thomsen JL,Breiting VB, Brandt B. Sin human breast tis-sue surrounding silicone gel prostheses.Scand J Plast Reconstr Surg Hand Surg1998;22:127-30.

  9. Silver RM, Sahn EE, Aleen JA, Sahn S, Gree-ne W, Maize JC, et al. Demonstration of silicone in sites of connective tissue disease inpatients with silicone gel breast implants.Arch Dermatol 1993;129:63-68.

  10. Vargas J, Schumacher R, Jiménez SA.Systemic sclerosis after augmentation mam-moplasty with silicone implants. Ann InternMed 1989;111: 377-87.

  11. Leong AS, Disney AP, Gove DW. Retractile particles in liver of hemodyalisis patients. Lancet 1981;1:889-90.

  12. Bomer J, Ritz E, Walsherr R. Silicone-induced splenomegaly. Treatment of pancytopenia by splenectomia in a patient on hemodialysis. N Engl J Med 1981;305:1077-79.

  13. Achauer BM. A serious complication following medical-grade silicone injection of the face. Plast Reconstr Surg 1983;71:251-53.

  14. Lombardi T, Samson J, Plantier F , Husson C, Kuffer R. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med 2004;33:115-20.

  15. Mastruserio N, Pesqueira MJ, Cobb M W. Severe granulomatous reaction and facial ulceration ocurring alter subcutaneous silicone injection. J Am Acad Dermatol 1996;34:849-52.

  16. Pearl RM, Laub DR, Kaplal EN. Complications following silicone injections for augmentation of the contour of the face. Plast Reconstr Surg 1983;71:251-53.

  17. Rapaport MJ, Vinnik C, Zarem H. Injectable silicone. Cause of facial nodules, cellulities,ulceration, and migration. Aesth Plast Surg1996;20:267-76.

  18. Travis WD, Balough K, Abraham JL. Silicone granulomas: report of three cases andreview of the literature. Hum Pathol1985;16:19-27.19.Wilkie TF. Late development of granulomaafter liquid silicone injections. Plast ReconstrSurg 1977;60:179-88.

  19. Rubio Flores C, Martín Díaz MªA, Quesada Cortés A, Vidaurrázaga y Díaz Arcaya C,Regajo Zapata RMª, Casado Jiménez M.Granulomas por silicona en regiones preti-biales tras su inyección en región glútea.MedCutan Iber Lat Am2007;35:149-51.

  20. Christensen LC, Breiting VB, Aasted A, Jorgensen A, Kebuladze I. Long term effects of polyacrylamide hydrogel (PAAG, Interfall /Contura SA) in human breast tissue. PlastReconstr Surg2003;111:1883-90.

  21. Gómez-De la Fuente E, Álvarez-Fernández JG, Pinedo F, Naz E, Gamo R, Vicente-Martín FJ, López-Estebaranz JL. Reacción cutá-nea tras implante con Bio-Alcamid®. ActasDermosifiliogr2007;98:271-5.

  22. Lemperle G, Ott H, Charrier U, Hecker J, Lemperle M. PMMA microspheres for intradermal implantation. Part I. Animal rese-arch. Ann Plast Surg1991;26:57-63.

  23. Kamer FM, Churukian MM. Clinical use of injectable collagen. A three-year retrospective review. Arch Otolaryngol1984;110:93-98.

  24. Krauss MC. Recent advances in soft tissue augmentation. Semin Cutan Med Surg1999;18:119-28.

  25. Reisberg EM, Landthaler M, Wiest L, Schroder J, Stolz W. Foreign body granulomatous caused by polymeylmethacrylate micros-pheres. ArchDermatol2003;139:17-20.

  26. Duranti F, Salti G, Bovani Bcalandra M, Rosati ML. Injectable hyalurinic acid for sof ttissue augmentation. A clinical and histologi-cal study. DermatolSurg1998;24:1317-25.

  27. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid. Dermatol Surg2000;26:135-37.

  28. Bergeret-Galley C, Latouche X, Illouz YG. The value of a new filler material in corrective and cosmetic surgery: dermaLive and Der-maDeep. Aesth Plast Surg2001;25:249-55.

  29. Moe KS, Weisman RA. Resorbable fixation infacial plastic and head and neck reconstructive surgery: an initial report of polylactic acidimplants. Laryngoscope2001;111:1697-1701.

  30. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review. DermatolSurg 2005;31:1616-25.

  31. Pollack SV. Some new injectable dermal filler materials: Hylaform®, Restylane®and Artecoll®. J Cutan Med Surg1999;Suppl. 4:527-32.

  32. Lemperle G, Romano JJ, Busso M. Soft tisue augmentation with Artecoll®: 10-year history, indications, techniques and complications.Dermatol Surg2003;29:573-87.

  33. Mullins RJ, Richards C, Walker T. Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons.Aust N Z J Ophthalmol1996;24:257-60.

  34. Klein AW. Collagen substances. Facial Plast Surg Clin North Am2001;9:205-18.

  35. Lowe NJ, Maxwell CA, Lowe P, Duik MG,Shah K. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Der-matol 2001;45:930-3.

  36. Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable non animal stabilized hyaluronic acid gel for soft tis-sue augmentation. Dermatol Surg 2002;28:491-4.

  37. Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, et al. Polylactic acid implants (New-Fill) to correctfacial lipoatrophy in HIV-infected patients:results of the open-label study VEGA. AIDS2003;17:2471-7.

  38. Maas CS, Papel ID, Greene D, Stoker DA. Complications of injectable synthetic polymers in facial augmentation.Dermatol Surg 1997;23:871-7.

  39. Duranti F, Salti G, Bovani B, Calandra M, Rosati ML. Injectable hyaluronic gel for soft tissue augmentation. Dermatol Surg 1998;24:1317-25.

  40. Rudolph CM, Soyer HP, Schuller-Petrovic S, Kerl H. Foerign body granulomas due to injectable aesthetic microimplants. Am JSurg Pathol 1999;23:113-7.

  41. Requena C, Izquierdo MJ, Navarro M, Martinez A, Vilalta JJ, Botella R, et al. Adverse reactions to injectable aesthetic microim-plants. Am J Dermatopathol2001;23:197-202.

  42. Ficarra G, Mosqueda-Taylor A, Carlos R. Silicone granuloma of the facial tissue: a report of seven cases. Oral Surg Oral Med OralPathol Oral Radiol Endod2002;94:65-73.

  43. Senet P, Backclez H, Ollivaud L. Minocyclinefor the treatment of cutaneous silicone granulomas. Br J Dermatol 1999;140:985-7.

  44. Syed TA, A review of the applications of imiquimod. A novel immune response modifier. Expert Opin Pharmacother 2001;2:877-882.

  45. Zeller JM. Surgical implants. Physiological response. AORNJ 1983;37:1284-91.

  46. Jansen T, Kossmann E, Plewig G. Siliconoma. An interdisciplinary problem. Hautarzt 1993;44:636-43.

  47. Zabel P, Entzian P, Dalhoff k, Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med1997;155:1665-9.

  48. Teuber SS, Reilly DA, Howell L, Oide C, Gershwin ME. Severe migratory granulomatous reactions to silicone gel in 3 patients. J Rheumatol1999;26:699-704.

  49. Bergeret-Galley C. Comparison of resorbablesoft tissue fillers. Aesthetic Surg J 2004;24:33-46.

  50. LaGlenne E. Letter to the editor: in response to: case report: episodes of angioedema of the face with nodules and foreign body granulomas to years after injection of a productfor filling wrinkles: New-Fill probably the res-ponsible agent. Nouv Dermatol2004;23:223-4.

  51. Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg2003;29:971-3.

  52. Stegman SJ, Chu S, Armstrong R. Adverse reactions to bovine collagen implants: clinical and histologic features. J Dermatol SurgOncol 1998;14:539-48.

  53. Hanke CW, Hingley HR, Jolivette DM, Swanson NA, Stegman JJ. Abscess formation and local necrosis after treatment with Zyderm® or Zyplast®collagen implant. J Am AcadDermatol1991;25:319-26.

  54. McGrew F, Wilson RS, Havener W. Sudden blindness secondary to injection of common drugs in the head and neck: I. Clinical experiences. Otolaryngology1978;86:147-51.




2020     |     www.medigraphic.com